Skip to content
healthcare.dev

Lamivudine

NDC 31722-754, Lamivudine, tablet, film coated, from Camber Pharmaceuticals, Inc..

Product NDC
31722-754
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203277
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-754 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMIVUDINE300 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
31722-754-0631722075406600 TABLET, FILM COATED in 1 BOTTLE (31722-754-06)
31722-754-303172207543030 TABLET, FILM COATED in 1 BOTTLE (31722-754-30)
31722-754-313172207543110 TABLET, FILM COATED in 1 BLISTER PACK (31722-754-31)
31722-754-3231722075432100 TABLET, FILM COATED in 1 CARTON (31722-754-32)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/49d53e74-3798-4463-b817-1c8beb755034

Use it

Look up 31722-754 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-754 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-754. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.